393 related articles for article (PubMed ID: 27683760)
1. Pathophysiological relevance of macrophage subsets in atherogenesis.
Liberale L; Dallegri F; Montecucco F; Carbone F
Thromb Haemost; 2017 Jan; 117(1):7-18. PubMed ID: 27683760
[TBL] [Abstract][Full Text] [Related]
2. Macrophage phenotypes in atherosclerosis.
Colin S; Chinetti-Gbaguidi G; Staels B
Immunol Rev; 2014 Nov; 262(1):153-66. PubMed ID: 25319333
[TBL] [Abstract][Full Text] [Related]
3. Changes in transcriptome of macrophages in atherosclerosis.
Chistiakov DA; Bobryshev YV; Orekhov AN
J Cell Mol Med; 2015 Jun; 19(6):1163-73. PubMed ID: 25973901
[TBL] [Abstract][Full Text] [Related]
4. Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation.
Li H; Cao Z; Wang L; Liu C; Lin H; Tang Y; Yao P
Front Immunol; 2022; 13():843712. PubMed ID: 35432323
[TBL] [Abstract][Full Text] [Related]
5. [Macrophage activation in atherosclerosis. Message 1: Activation of macrophages normally and in atherosclerotic lesions].
Nikiforov NG; Kornienko VY; Karagodin VP; Orekhov AN
Patol Fiziol Eksp Ter; 2015; (3):128-31. PubMed ID: 26852607
[TBL] [Abstract][Full Text] [Related]
6. Diversity of macrophage phenotypes and responses in atherosclerosis.
Jinnouchi H; Guo L; Sakamoto A; Torii S; Sato Y; Cornelissen A; Kuntz S; Paek KH; Fernandez R; Fuller D; Gadhoke N; Surve D; Romero M; Kolodgie FD; Virmani R; Finn AV
Cell Mol Life Sci; 2020 May; 77(10):1919-1932. PubMed ID: 31720740
[TBL] [Abstract][Full Text] [Related]
7. Voltage-gated sodium channel inhibitor reduces atherosclerosis by modulating monocyte/macrophage subsets and suppressing macrophage proliferation.
Sun H; Jiang J; Gong L; Li X; Yang Y; Luo Y; Guo Z; Lu R; Li H; Li J; Zhao J; Yang N; Li Y
Biomed Pharmacother; 2019 Dec; 120():109352. PubMed ID: 31586905
[TBL] [Abstract][Full Text] [Related]
8. Macrophage profiling in atherosclerosis: understanding the unstable plaque.
Gianopoulos I; Daskalopoulou SS
Basic Res Cardiol; 2024 Feb; 119(1):35-56. PubMed ID: 38244055
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Phenotype and Function in Different Stages of Atherosclerosis.
Tabas I; Bornfeldt KE
Circ Res; 2016 Feb; 118(4):653-67. PubMed ID: 26892964
[TBL] [Abstract][Full Text] [Related]
10. STAT6 Upregulation Promotes M2 Macrophage Polarization to Suppress Atherosclerosis.
Gong M; Zhuo X; Ma A
Med Sci Monit Basic Res; 2017 Jun; 23():240-249. PubMed ID: 28615615
[TBL] [Abstract][Full Text] [Related]
11. CXCL4-induced macrophages in human atherosclerosis.
Domschke G; Gleissner CA
Cytokine; 2019 Oct; 122():154141. PubMed ID: 28899579
[TBL] [Abstract][Full Text] [Related]
12. BMP-7 Treatment Increases M2 Macrophage Differentiation and Reduces Inflammation and Plaque Formation in Apo E-/- Mice.
Singla DK; Singla R; Wang J
PLoS One; 2016; 11(1):e0147897. PubMed ID: 26824441
[TBL] [Abstract][Full Text] [Related]
13. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation.
Wolfs IM; Donners MM; de Winther MP
Thromb Haemost; 2011 Nov; 106(5):763-71. PubMed ID: 21947328
[TBL] [Abstract][Full Text] [Related]
14. Vascular Macrophages in Atherosclerosis.
Xu H; Jiang J; Chen W; Li W; Chen Z
J Immunol Res; 2019; 2019():4354786. PubMed ID: 31886303
[TBL] [Abstract][Full Text] [Related]
15. Macrophage subsets in atherosclerosis.
Chinetti-Gbaguidi G; Colin S; Staels B
Nat Rev Cardiol; 2015 Jan; 12(1):10-7. PubMed ID: 25367649
[TBL] [Abstract][Full Text] [Related]
16. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
17. Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORĪ±-dependent manner.
Ding S; Lin N; Sheng X; Zhao Y; Su Y; Xu L; Tong R; Yan Y; Fu Y; He J; Gao Y; Yuan A; Ye L; Reiter RJ; Pu J
J Pineal Res; 2019 Sep; 67(2):e12581. PubMed ID: 31009101
[TBL] [Abstract][Full Text] [Related]
18. Macrophages and Dendritic Cells: Partners in Atherogenesis.
Cybulsky MI; Cheong C; Robbins CS
Circ Res; 2016 Feb; 118(4):637-52. PubMed ID: 26892963
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis.
Gleissner CA
Front Physiol; 2012; 3():1. PubMed ID: 22275902
[TBL] [Abstract][Full Text] [Related]
20. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy.
Momtazi-Borojeni AA; Abdollahi E; Nikfar B; Chaichian S; Ekhlasi-Hundrieser M
Heart Fail Rev; 2019 May; 24(3):399-409. PubMed ID: 30673930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
